Jayson Bedford Analyst PerformanceManaging Director Medical Technology at Raymond James FinancialJayson Bedford is a stock analyst at Raymond James Financial in the medical sector, covering 16 publicly traded companies. Over the past year, Jayson Bedford has issued 22 stock ratings, including strong buy, buy, and hold recommendations. While full access to Jayson Bedford's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jayson Bedford's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings48 Last 10 YearsBuy Recommendations95.74% 45 Buy RatingsCompanies Covered16 Unique Companies Ratings Distribution47RatingsDistribution of strong buy, buy, hold, and sell ratings by Jayson Bedford.RatingPercentageCount Strong Buy14.9%7 ratings Buy80.9%38 ratings Hold4.3%2 ratings Sell0.0%0 ratingsOut of 47 total stock ratings issued by Jayson Bedford at Raymond James Financial, the majority (80.9%) have been Buy recommendations, followed by 14.9% Strong Buy and 4.3% Hold.Best & Worst CallsBest Call000.0%MMSIFeb 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%BAXFeb 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ56.3% of companies on NASDAQ9 companiesNYSE43.8% of companies on NYSE7 companiesJayson Bedford, an analyst at Raymond James Financial, currently covers 16 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical16 companies100.0%Jayson Bedford of Raymond James Financial specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED PRODUCTS7 companies43.8%MED INSTRUMENTS6 companies37.5%LARGE CAP PHARMA1 company6.3%MED/DENTAL - SUPP1 company6.3%MEDICAL INFO SYS1 company6.3% About Jayson BedfordJayson Bedford joined Raymond James Equity Research in 2006 as a senior analyst covering medical devices. Prior to joining Raymond James, Bedford covered the medical devices sector for Adams, Harkness & Hill (now Canaccord Genuity) for more than five years. He also worked as a research associate in the sector at Advest, Inc. He has been quoted in Business Week and Investor’s Business Daily, and has been a guest speaker on CNBC. Bedford received his B.A. from Michigan State University, where he also received All-Big Ten honors, Academic All-Big Ten honors and competed in the NCAA Tennis Championship. He also holds an MBA from the University of Massachusetts at Amherst, graduating with honors.Follow on LinkedIn Jayson Bedford's Ratings History at Raymond James Financial Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsTFXTeleflex5/8/2026Reiterated Rating$131.65$150.00Outperform$0.0000.00% ROIBSXBoston Scientific3/30/2026Reiterated Rating$69.21$88.00Outperform$0.0000.00% ROITFXTeleflex3/27/2026Upgrade$110.48$128.00Outperform$0.0000.00% ROIMASIMasimo3/27/2026Downgrade$176.89Market Perform$0.0000.00% ROIAXGNAxoGen2/23/2026Reiterated Rating$35.30$41.00Outperform$0.0000.00% ROIISRGIntuitive Surgical1/23/2026Boost Price Target$525.81$615.00Outperform$0.0000.00% ROIABTAbbott Laboratories1/23/2026Lower Price Target$108.50$130.00Outperform$0.0000.00% ROIAXGNAxoGen12/4/2025Reiterated Rating$33.29$36.00Outperform$0.0000.00% ROIEWEdwards Lifesciences11/3/2025Upgrade$82.48$96.00Outperform$0.0000.00% ROIAXGNAxoGen10/30/2025Boost Price Target$22.31$27.00Outperform$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. ISRGIntuitive Surgical10/22/2025Set Price Target$540.05$603.00Outperform$0.0000.00% ROICBLLCeriBell10/21/2025Initiated Coverage$12.50$19.00Strong-Buy$0.0000.00% ROIABTAbbott Laboratories10/16/2025Boost Price Target$129.58$146.00Outperform$0.0000.00% ROIJNJJohnson & Johnson10/15/2025Boost Price Target$190.88$209.00Outperform$0.0000.00% ROIICUIICU Medical8/8/2025Lower Price Target$112.54$180.00Strong-Buy$0.0000.00% ROIZBHZimmer Biomet8/8/2025Boost Price Target$98.24$113.00Outperform$0.0000.00% ROIMMSIMerit Medical Systems7/31/2025Lower Price Target$83.66$102.00Outperform$0.0000.00% ROIDXCMDexCom7/31/2025Boost Price Target$84.33$102.00Strong-Buy$0.0000.00% ROIBSXBoston Scientific7/24/2025Boost Price Target$105.58$124.00Strong-Buy$0.0000.00% ROIBSXBoston Scientific7/21/2025Set Price Target$103.85$121.00Strong-Buy$0.0000.00% ROIABTAbbott Laboratories7/18/2025Lower Price Target$124.46$141.00Outperform$0.0000.00% ROIPODDInsulet5/27/2025Reiterated Rating$326.80$360.00Outperform$0.0000.00% ROIZBHZimmer Biomet5/6/2025Lower Price Target$91.47$104.00Outperform$00.0000.00% ROIMMSIMerit Medical Systems4/25/2025Lower Price Target$93.76$108.00Outperform$00.0000.00% ROIABTAbbott Laboratories4/17/2025Boost Price Target$131.84$142.00Outperform$00.0000.00% ROIJNJJohnson & Johnson4/14/2025Lower Price Target$153.67$162.00Outperform$000.0000.00% ROIPODDInsulet2/21/2025Reiterated Rating$283.32$328.00Outperform$000.0000.00% ROIZBHZimmer Biomet2/7/2025Lower Price Target$101.77$119.00Outperform$00.0000.00% ROIBSXBoston Scientific2/6/2025Boost Price Target$105.29$122.00Strong-Buy$00.0000.00% ROIBSXBoston Scientific1/31/2025Boost Price Target$103.16$119.00Strong-Buy$00.0000.00% ROIISRGIntuitive Surgical1/24/2025Boost Price Target$587.06$688.00Outperform$000.0000.00% ROIJNJJohnson & Johnson1/23/2025Lower Price Target$145.39$165.00Outperform$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
